LC
CELG

Lindbrook Capital’s Celgene Corp CELG Stock Holding History

Lindbrook Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-829
Closed -$82K – 1596
2019
Q3 		$82K Buy
829
+103
+14% +$9.79K 0.03% 281
2019
Q2 		$67K Buy
726
+122
+20% +$11.6K 0.03% 333
2019
Q1 		$56K Buy
604
+255
+73% +$22.3K 0.02% 368
2018
Q4 		$22K Buy
+349
New +$25.8K 0.01% 589

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Lindbrook Capital's CELG Position: Q4 2019 in Review

Lindbrook Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 829 shares — an estimated $82K sold.

Lindbrook Capital first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $82K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Lindbrook Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Lindbrook Capital sold 829 Celgene Corp shares in Q4 2019, an estimated $82K.
  • Lindbrook Capital first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Lindbrook Capital's Celgene Corp position peaked at $82K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Lindbrook Capital's 13F filing for Q4 2019, filed 27 Jan 2020.